Tag: acasti pharma

September 30, 2019

Acasti Pharma Releases Additional Phase 3 Milestones

The company said that almost 80 percent of the patients in the Phase 3 TRILOGY trial have completed randomization in...
September 9, 2019

Acasti Pharma Receives Funding from the Government of Canada

Acasti Pharma (NASDAQ:ACST, TSXV:ACST) has announced the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) has awarded it...
July 28, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Acasti Up Again

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
July 21, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Acasta in Lead

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
July 4, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

We're halfway through the year, which means it's time to reflect on the top performing NASDAQ pharma stocks year-to-date.
December 31, 2018

Acasti Pharma Announces Data on TRILOGY Phase 3 Trials of CaPre in Patients

Acasti Pharma (NASDAQ:ACST;TSXV:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre (omega-3...
December 30, 2018

5 Top Weekly NASDAQ Biotech Stocks: Dova Up 41 Percent

Dova Pharmaceuticals, Sesen Bio, Adaptimmune Therapeutics, Mustang Bio and Equillium were last week's top gainers.